The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 103 (4) , 615-621
- https://doi.org/10.1016/s0091-6749(99)70233-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthmaJournal of Allergy and Clinical Immunology, 1998
- Stereoselective metabolism ofRS-albuterol in humansClinical Reviews in Allergy & Immunology, 1996
- Effects of albuterol enantiomers on in vitro bronchial reactivityClinical Reviews in Allergy & Immunology, 1996
- S-albuterol exacerbates calcium responses to carbachol in airway smooth muscle cellsClinical Reviews in Allergy & Immunology, 1996
- Comparison ofR-, S-, andRS-albuterol interaction with human β1 and β2-adrenergic receptorsClinical Reviews in Allergy & Immunology, 1996
- AlbuterolClinical Reviews in Allergy & Immunology, 1996
- Enantioselective disposition of salbutamol in man following oral and intravenous administrationBritish Journal of Clinical Pharmacology, 1996
- Albuterol treatment for children with asthma: A comparison of inhaled powder and aerosolJournal of Allergy and Clinical Immunology, 1989
- Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.Archives of Disease in Childhood, 1981
- Absolute configuration of the optical isomers of salbutamolJournal of Medicinal Chemistry, 1971